1. Home
  2. BLBD vs PCRX Comparison

BLBD vs PCRX Comparison

Compare BLBD & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLBD
  • PCRX
  • Stock Information
  • Founded
  • BLBD 1927
  • PCRX 2006
  • Country
  • BLBD United States
  • PCRX United States
  • Employees
  • BLBD N/A
  • PCRX N/A
  • Industry
  • BLBD Construction/Ag Equipment/Trucks
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BLBD Consumer Discretionary
  • PCRX Health Care
  • Exchange
  • BLBD Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • BLBD 1.1B
  • PCRX 1.1B
  • IPO Year
  • BLBD N/A
  • PCRX 2011
  • Fundamental
  • Price
  • BLBD $33.71
  • PCRX $24.65
  • Analyst Decision
  • BLBD Strong Buy
  • PCRX Buy
  • Analyst Count
  • BLBD 7
  • PCRX 9
  • Target Price
  • BLBD $58.21
  • PCRX $30.11
  • AVG Volume (30 Days)
  • BLBD 527.0K
  • PCRX 1.2M
  • Earning Date
  • BLBD 05-07-2025
  • PCRX 05-06-2025
  • Dividend Yield
  • BLBD N/A
  • PCRX N/A
  • EPS Growth
  • BLBD 69.33
  • PCRX N/A
  • EPS
  • BLBD 3.21
  • PCRX N/A
  • Revenue
  • BLBD $1,343,366,000.00
  • PCRX $700,966,000.00
  • Revenue This Year
  • BLBD $8.82
  • PCRX $9.48
  • Revenue Next Year
  • BLBD $7.91
  • PCRX $11.31
  • P/E Ratio
  • BLBD $10.50
  • PCRX N/A
  • Revenue Growth
  • BLBD 10.59
  • PCRX 3.85
  • 52 Week Low
  • BLBD $30.04
  • PCRX $11.16
  • 52 Week High
  • BLBD $59.40
  • PCRX $31.67
  • Technical
  • Relative Strength Index (RSI)
  • BLBD 49.45
  • PCRX 51.22
  • Support Level
  • BLBD $32.61
  • PCRX $24.10
  • Resistance Level
  • BLBD $35.43
  • PCRX $25.35
  • Average True Range (ATR)
  • BLBD 2.08
  • PCRX 1.49
  • MACD
  • BLBD 0.18
  • PCRX 0.01
  • Stochastic Oscillator
  • BLBD 68.09
  • PCRX 48.89

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: